Study of EXPAREL in Patients Undergoing Breast Augmentation

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

MammoplastyPostoperative Pain

Interventions

DRUG

Instillation - EXPAREL

Intravenous (IV) morphine sulfate, hydromorphone, or oral oxycodone with acetaminophen (5/325 mg) will be permitted following surgery, as needed.

DRUG

Infiltration - EXPAREL

IV morphine sulfate, hydromorphone, or oral oxycodone with acetaminophen (5/325 mg) will be permitted following surgery, as needed.

Trial Locations (1)

Steward St. Elizabeth's Medical Center, Brighton